KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Amgen (AMGN) over the last 15 years, with Q4 2025 value amounting to $1.3 billion.

  • Amgen's Dividends Paid - Common rose 647.3% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 billion, marking a year-over-year increase of 604.3%. This contributed to the annual value of $5.1 billion for FY2025, which is 604.3% up from last year.
  • Amgen's Dividends Paid - Common amounted to $1.3 billion in Q4 2025, which was up 647.3% from $1.3 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Dividends Paid - Common peaked at $1.3 billion during Q4 2025, and registered a low of $990.0 million during Q4 2021.
  • Moreover, its 5-year median value for Dividends Paid - Common was $1.1 billion (2023), whereas its average is $1.1 billion.
  • Its Dividends Paid - Common has fluctuated over the past 5 years, first soared by 297.62% in 2022, then skyrocketed by 982.66% in 2023.
  • Quarter analysis of 5 years shows Amgen's Dividends Paid - Common stood at $990.0 million in 2021, then rose by 5.05% to $1.0 billion in 2022, then grew by 9.62% to $1.1 billion in 2023, then rose by 5.7% to $1.2 billion in 2024, then grew by 6.47% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $1.3 billion for Q3 2025, and $1.3 billion during Q2 2025.